Self-Healing Juvenile Cutaneous Mucinosis: A Case Report in the Middle East.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
16 Jan 2019
Historique:
entrez: 17 1 2019
pubmed: 17 1 2019
medline: 27 3 2019
Statut: epublish

Résumé

BACKGROUND Self-healing juvenile cutaneous mucinosis (SHJCM) is a rarely diagnosed disease worldwide, with less than 20 reported cases in the literature. It is characterized by a rather benign course in juvenile patients with nodular and mucinous skin eruption and edema. CASE REPORT A 12-year-old male patient previously healthy presented to the pediatrics clinic with a 1-week history of bilateral palmer pruritus and plantar tenderness upon walking, preceded by eruption of erythematous patch on his neck. The disease course evolved to include facial edema, erythema, nodular skin eruptions with a completely negative initial workup. The patient was labelled as a juvenile idiopathic arthritis patient and doomed to be a candidate for corticosteroid therapy. Upon further workup, a skin biopsy was taken and SHJCM was diagnosed. Complete resolution of symptoms was witnessed on symptomatic treatment after 5 months of diagnosis. CONCLUSIONS To our knowledge, this is the second case of SHJCM reported in the Middle East and the first to be reported in Lebanon. It is also the first case reported to have the longest follow-up period; 10 years of follow-up with no new findings or relapse. SHJCM is a rare disease whereby awareness of its features and presentation may help in diagnosing it and preventing unnecessary testing and aggressive treatment for a rather benign disease.

Identifiants

pubmed: 30647403
pii: 910047
doi: 10.12659/AJCR.910047
pmc: PMC6345112
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

65-69

Références

Dermatology. 1999;199(1):57-9
pubmed: 10449960
J Am Acad Dermatol. 2001 Feb;44(2):273-81
pubmed: 11174386
Acta Derm Venereol. 2002;82(2):145-6
pubmed: 12125950
Pediatr Dermatol. 2003 Jan-Feb;20(1):35-9
pubmed: 12558844
Am J Clin Pathol. 1955 Mar;25(3):241-52
pubmed: 14361319
J Am Acad Dermatol. 2004 May;50(5 Suppl):S97-100
pubmed: 15097940
J Am Acad Dermatol. 2006 Dec;55(6):1036-43
pubmed: 17110219
J Dtsch Dermatol Ges. 2014 Sep;12(9):815-7
pubmed: 25176461
Reumatologia. 2017;55(1):53-56
pubmed: 28386144
J Am Acad Dermatol. 1984 Aug;11(2 Pt 2):327-32
pubmed: 6480937
Ann Dermatol Venereol. 1980 Jan-Feb;107(1-2):51-7
pubmed: 7369658
Arch Dermatol. 1995 Apr;131(4):459-61
pubmed: 7726590
Clin Exp Dermatol. 1994 Jan;19(1):90-3
pubmed: 8313651
Dermatology. 1996;192(3):268-70
pubmed: 8726646

Auteurs

Caroline Geagea (C)

Department of Pediatrics and Adolescent Medicine, Lebanese American University Medical Center, Beirut, Lebanon.

Nour Youssef (N)

Department of Pediatrics and Adolescent Medicine, Lebanese American University Medical Center, Beirut, Lebanon.

Gerard Wakim (G)

Department of Pediatrics and Adolescent Medicine, Lebanese American University Medical Center, Beirut, Lebanon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH